170 related articles for article (PubMed ID: 27819522)
1. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).
Gudbrandsdottir S; Ghanima W; Nielsen CH; Feng X; Hasselbalch HC; Bussel J
Platelets; 2017 Jul; 28(5):478-483. PubMed ID: 27819522
[TBL] [Abstract][Full Text] [Related]
2. Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia.
Qu MM; Liu XN; Liu XG; Feng Q; Liu Y; Zhang X; Liu S; Zhang L; Li GS; Zhu YY; Lv MY; Peng J; Hou M
Cytokine; 2017 Apr; 92():110-117. PubMed ID: 28142109
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
Makar RS; Zhukov OS; Sahud MA; Kuter DJ
Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
[TBL] [Abstract][Full Text] [Related]
4. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia.
Alvarez Román MT; Fernández Bello I; Arias-Salgado EG; Rivas Pollmar MI; Jiménez Yuste V; Martín Salces M; Butta NV
Thromb Haemost; 2014 Jul; 112(1):65-72. PubMed ID: 24500066
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.
Feng X; Scheinberg P; Samsel L; Rios O; Chen J; McCoy JP; Ghanima W; Bussel JB; Young NS
J Thromb Haemost; 2012 Aug; 10(8):1616-23. PubMed ID: 22537155
[TBL] [Abstract][Full Text] [Related]
7. Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists.
Garabet L; Ghanima W; Hellum M; Sandset PM; Bussel JB; Tran H; Henriksson CE
Platelets; 2020; 31(3):322-328. PubMed ID: 31280643
[TBL] [Abstract][Full Text] [Related]
8. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study.
Åkesson A; Bussel JB; Martin M; Blom AM; Klintman J; Ghanima W; Zetterberg E; Garabet L
Platelets; 2023 Dec; 34(1):2159019. PubMed ID: 36636835
[TBL] [Abstract][Full Text] [Related]
9. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
10. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults.
Červinek L; Mayer J; Doubek M
Int J Hematol; 2015 Jul; 102(1):7-11. PubMed ID: 25833724
[TBL] [Abstract][Full Text] [Related]
11. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
Ghanima W; Junker P; Hasselbalch HC; Boiocchi L; Geyer JT; Feng X; Gudbrandsdottir S; Orazi A; Bussel JB
Br J Haematol; 2011 Oct; 155(2):248-55. PubMed ID: 21902682
[TBL] [Abstract][Full Text] [Related]
12. Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura.
Bal G; Fabian D; Maia D; Ringel F; Salama A
Ann Hematol; 2017 Dec; 96(12):2045-2056. PubMed ID: 28965224
[TBL] [Abstract][Full Text] [Related]
13. Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists.
Justo Sanz R; Monzón Manzano E; Fernández Bello I; Teresa Álvarez Román M; Martín Salces M; Rivas Pollmar MI; Jiménez Yuste V; Butta NV
Thromb Haemost; 2019 Apr; 119(4):645-659. PubMed ID: 30743272
[TBL] [Abstract][Full Text] [Related]
14. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
Mahévas M; Fain O; Ebbo M; Roudot-Thoraval F; Limal N; Khellaf M; Schleinitz N; Bierling P; Languille L; Godeau B; Michel M
Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia.
Li S; Shao J; Xia M; Zhang N; Yang J; Li H; Jiang H
Hematology; 2018 Aug; 23(7):433-438. PubMed ID: 29313460
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
18. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura.
Mukai HY; Kojima H; Todokoro K; Tahara T; Kato T; Hasegawa Y; Kobayashi T; Ninomiya H; Nagasawa T; Abe T
Thromb Haemost; 1996 Nov; 76(5):675-8. PubMed ID: 8950771
[TBL] [Abstract][Full Text] [Related]
19. Altered cytokine levels in pediatric ITP.
Jernås M; Hou Y; Strömberg Célind F; Shao L; Wang Q; Ju X; Mellgren K; Wadenvik H; Hou M; Olsson B
Platelets; 2015; 26(6):589-92. PubMed ID: 25806433
[TBL] [Abstract][Full Text] [Related]
20. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura.
Kosugi S; Kurata Y; Tomiyama Y; Tahara T; Kato T; Tadokoro S; Shiraga M; Honda S; Kanakura Y; Matsuzawa Y
Br J Haematol; 1996 Jun; 93(3):704-6. PubMed ID: 8652398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
